0.69 USD
▲-0.01+1.15%
盘后 0.71 +4.19%
2026-08-03
市值
$108.67M
市盈率
—
EPS
-1.05
股息率
—
52 周区间
0.38 – 2.45
成交量
706.27K
Beta
2.32
目标价
5.03
52W 低 0.3852W 高 2.45
价格走势
公司简介
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. It develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. The company also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably alteri...